[Solved]: A patient has been receiving pembrolizumab for six…

A patient has been receiving pembrolizumab for six weeks and is concerned because there seems to be no change in their condition. In explaining how immunotherapy works, what is the most important factor for the nurse to consider? The patient should be reporting an improvement by week six. The lack of improvement means disease progression. It may take 12 to 16 weeks to see a response. Better biomarkers may be needed to evaluate efficacy. 2